Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.
about
Ayurveda interventions for rheumatoid arthritisMy treatment approach to rheumatoid arthritisEffects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data.Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review.Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA studyRheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbiditiesA marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?Time to achieve remission determines time to be in remission.Remission in rheumatoid arthritis.Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter?Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of tTreating rheumatoid arthritis to target: recommendations of an international task force.American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria.The challenging interplay between rheumatoid arthritis, ageing and comorbidities.Sustained rheumatoid arthritis remission is uncommon in clinical practice.Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis -- results from the DANBIO registry.Smoking Functions as a Negative Regulator of IGF1 and Impairs Adipokine Network in Patients with Rheumatoid ArthritisSignificance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up.Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis.Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conferenceDisparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.Factors Contributing to Discordance between the 2011 ACR/EULAR Criteria and Physician Clinical Judgment for the Identification of Remission in Patients with Rheumatoid Arthritis.Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients.Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system.Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia.Synovial tissue research: a state-of-the-art review.Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial.Remission makes its way to rheumatologyDisability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab.Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.Reexamination of the assessment criteria for rheumatoid arthritis disease activity based on comparison of the Disease Activity Score 28 with other simpler assessment methods.Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey.The good EULAR response at the first year is strongly predictive of clinical remission in rheumatoid arthritis: results from the TARAC cohort.
P2860
Q24187687-D5F15888-F2FF-45D6-BAE4-C81A119ADF0FQ26829955-7F4F918F-1EAE-40B1-97B8-E688A231E1D2Q30984829-199332C9-DB14-4387-BB75-04F4B0E19A63Q31123794-180BA599-C949-4A95-8B17-2416667D4FCDQ33535269-379CF9FA-666D-44F2-970C-7B1E0A4951BFQ33540305-67231E16-FB00-41D8-B856-DA88EDEBAF6FQ33675569-93560A1B-C5FF-43D7-9F07-A111F4A84A76Q33809755-31F33949-F543-4F83-8862-F1E17ABAD684Q33907217-FFFF5697-A435-4909-80C1-CCE8281F68B4Q34027517-8792FC4C-0957-4249-BA95-EE12463233D7Q34081946-495A5FB9-8A65-47F3-AC4F-0EED6A929055Q34376211-08EA1B89-756B-49AC-8044-E3DE1EBC56F9Q34394122-EA552D02-F576-4B94-8EA7-DC30371FF9F0Q34462557-02260B03-4503-4958-A587-32A0D874AA3DQ35047250-F76F4CDA-092A-4CD7-9E30-DB1112A74131Q35449556-77A34F9D-1662-4BC0-97E1-C1248F738719Q36000249-59D972FE-3DE2-4003-98AD-F13572191A74Q36245761-30AE6151-D056-42DE-8CEE-E5BDDCD2F26DQ36584051-7040D2B8-0E94-4416-B5C9-53DB9C691552Q36693727-51022D0E-642B-4BD0-9520-BE4D03D493B3Q36706945-F15DF960-4509-444A-844E-3D8D187D7FCFQ36725890-DFCD6320-1637-4BB2-8086-066ED75175D8Q36975907-1F1BD8F9-6D03-4905-A52C-5365731B74D8Q37010967-EDA9F0AA-460E-4935-A92D-115E16F0B842Q37177578-33624154-2FDA-4D69-9F4D-E0D638288182Q37191449-FAE856BA-D366-45C1-BAF2-876571E4E6DFQ37374953-44C0EDC3-B5AD-4722-AD5A-1FA57511736AQ37404912-B31A8AF0-C4F6-44B2-B188-C5B19099FDC4Q37453985-CF7953BD-152E-4384-AFF5-FADFC0435181Q37552303-575EC45B-2A39-4B01-B303-F97E6D9516BEQ39046706-84AEF607-1F6B-4017-A45B-106479E64067Q39431367-28290046-4298-44FD-A36D-DA7038DB7B79Q40163454-CE908AFD-7E2A-4789-AB54-87FE94E33A77Q42368093-813F2F49-AF00-4F45-AF92-867B86D66D9FQ42420395-6C3A43D3-8DB4-4FC2-BF8D-4BA35378FAF3Q43752980-6F479DE0-175A-49F2-A312-8F3F5C56A4BEQ43867998-C4FD6E31-7CE9-4387-AC67-C2C22E7AAEC3Q44447375-70D57229-73C9-4C22-AF5D-91B8E85EEDBEQ45713588-2DB1FE6D-5CAC-4BC7-BCDE-74406580EBDBQ46081724-03E6E6D9-D249-4DDE-81ED-F75AB6E04810
P2860
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Remission and rheumatoid arthr ...... care in twenty-four countries.
@ast
Remission and rheumatoid arthr ...... care in twenty-four countries.
@en
type
label
Remission and rheumatoid arthr ...... care in twenty-four countries.
@ast
Remission and rheumatoid arthr ...... care in twenty-four countries.
@en
prefLabel
Remission and rheumatoid arthr ...... care in twenty-four countries.
@ast
Remission and rheumatoid arthr ...... care in twenty-four countries.
@en
P2093
P50
P356
P1476
Remission and rheumatoid arthr ...... care in twenty-four countries.
@en
P2093
Aleksander Dimić
Aleksandra Stanković
Alessia Morelli
Alexandros A Drosos
Ann-Carin Holmqvist
Bernard Combe
Ernest Choy
Hannu Kautiainen
Heidi Mäkinen
Humeira Badsha
P304
P356
10.1002/ART.23794
P50
P577
2008-09-01T00:00:00Z